ACHV (STOCKS)
Achieve Life Sciences, Inc.
$3.580000
+0.090000 (+2.58%)
Prev close: $3.490000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Richard Alistair Balfour Stewart
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $190.33M
- Employees
- 25
- P/E (TTM)
- -2.76
- P/B (TTM)
- 8.63
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
10
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.28 | $-0.28 | -0.0031 | -1.12% |
|
Sep 2025 (Q3)
|
$-0.28 | $-0.26 | -0.0177 | -6.75% |
|
Jun 2025 (Q2)
|
$-0.37 | $-0.37 | +0.0013 | +0.35% |
|
Mar 2025 (Q1)
|
$-0.37 | $-0.37 | +0.0006 | +0.16% |
Financial Statements
| Costs And Expenses | $54.88M |
| Nonoperating Income/Loss | $232.00K |
| Depreciation and Amortization | $228.00K |
| Income/Loss From Continuing Operations After Tax | -$54.65M |
| Income/Loss From Continuing Operations Before Tax | -$54.65M |
| Net Income/Loss | -$54.65M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$54.65M |
| Net Income/Loss Available To Common Stockholders, Basic | -$54.65M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.25 |
| Diluted Earnings Per Share | -$1.25 |
| Basic Average Shares | 43,594,652 |
| Diluted Average Shares | 43,594,652 |
| Assets | $41.79M |
| Current Assets | $39.89M |
| Cash | $36.40M |
| Other Current Assets | $3.49M |
| Noncurrent Assets | $1.90M |
| Fixed Assets | $3.00K |
| Other Non-current Assets | $1.90M |
| Liabilities | $20.27M |
| Current Liabilities | $9.08M |
| Wages | $1.92M |
| Other Current Liabilities | $7.16M |
| Noncurrent Liabilities | $11.19M |
| Equity | $21.52M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $21.52M |
| Liabilities And Equity | $41.79M |
| Net Cash Flow From Operating Activities | -$49.47M |
| Net Cash Flow From Operating Activities, Continuing | -$49.47M |
| Net Cash Flow From Investing Activities | $6.11M |
| Net Cash Flow From Investing Activities, Continuing | $6.11M |
| Net Cash Flow From Financing Activities | $51.53M |
| Net Cash Flow From Financing Activities, Continuing | $51.53M |
| Net Cash Flow | $8.17M |
| Net Cash Flow, Continuing | $8.17M |
| Comprehensive Income/Loss | -$54.67M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$54.67M |
| Other Comprehensive Income/Loss | -$21.00K |